Tech Company Financing Transactions
Azevan Pharmaceuticals Funding Round
Azevan Pharmaceuticals secured a $2.2 million funding round on 10/18/2013. Investors included private investors.
Transaction Overview
Company Name
Announced On
10/18/2013
Transaction Type
Venture Equity
Amount
$2,205,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Not a solicitation.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
116 Research Dr.
Bethlehem, PA 18015
USA
Bethlehem, PA 18015
USA
Phone
Website
Email Address
Overview
Azevan Pharmaceuticals is a small molecule drug development firm developing therapeutics to treat stress, mood, and behavior disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Neal Simon
VP - Bus. Development
Michael Brownstein
VP - Operations
Eve Damiano
Browse more venture capital transactions:
Prev: 10/18/2013: Osprey Medical venture capital transaction
Next: 10/18/2013: Everest venture capital transaction
Share this article
Where The Data Comes From
We document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs